US Patent 9550831 Method for treating psoriasis
Patent 9550831 was granted and assigned to Biotest AG on January, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+302 characters)
Article
Patent abstract
The present invention provides pharmaceutical composition for treating an autoimmune disease comprising a pharmaceutically acceptable carrier and an agent capable of activating CD4+CD25+ regulatory T cells, wherein the composition is to be administered to a subject at most every 3 days.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Infobox
Patent Inventor Names
Andrea Wartenberg-Demand0
Benjamin Daelken0
Christoph Bruecher0
Christoph Uherek0
Daniele Wolf0
Elmar Kraus0
Frank Osterroth0
Gregor Schulz0
Juergen Lindner0
Matthias Germer0
Sibylle Kaiser0
Silke Aigner0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09550831 Method for treating psoriasis US Patent 9550831 Method for treating psoriasis
Infobox
Patent Number
095508310
Patent Number
95508310
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
095508310
Date of Patent
January 24, 2017
0Patent Application Number
128807680
Date Filed
September 13, 2010
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09550831 Method for treating psoriasis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09550831
Date of patent
January 24, 2017
Patent application number
12880768
Date Filed
September 13, 2010
Patent primary examiner
Find more entities like US Patent 9550831 Method for treating psoriasis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.